The article highlights the escalating cost of medicine in the U.S. and proposes regulatory changes, including limiting the influence of pharmacy-benefit managers, as potential solutions. This issue impacts consumer spending and healthcare sector profitability.
US Medicine Costs Under Scrutiny, Policy Solutions Proposed
healthcare-policydrug-pricingregulationUS-economypharmaceuticals